1.
Xu H, Wang D, Ramponi C, Wang X, Zhang H. The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease. IJDDP [Internet]. 2022 Dec. 21 [cited 2025 May 28];1(1):5. Available from: https://w3.sciltp.com/journals/ijddp/article/view/179